Methods of producing substituted (4R,12AS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-B][1,3]oxazine-9-carboxamides

Patent metadata

Field	Value
Publication number	US-9321789-B2
Application number	US-201414518209-A
Country	US
Kind code	B2
Filing date	Oct 20, 2014
Priority date	Aug 5, 2010
Publication date	Apr 26, 2016
Grant date	Apr 26, 2016

Abstract

A process for preparing a compound represented by formula (Y1) or (Y2)

wherein R x is an optionally substituted carbocyclyl lower alkyl, or the like or a salt thereof, using a novel process for preparing a pyridone derivative represented by formula (X4) wherein R 1d , R 2d , and R 4d are as defined herein.

First claim

What is claimed is:

1. A method of producing a compound shown by formula (Y1) or a pharmaceutically acceptable salt thereof:

(wherein R x is carbocyclyl optionally substituted by substituent E, heterocyclyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E
comprising the following steps:
(Step C)
reacting the compound shown by formula (X3),

with a compound shown by formula (V3):

to obtain a compound shown by formula (X4)

(Step D)
reacting the compound shown by formula (X4)
wherein
R 1d is hydrogen, halogen, lower alkyloxy optionally substituted by substituent E, carbocyclyl lower alkyloxy optionally substituted by substituent E, heterocyclyl lower alkyloxy optionally substituted by substituent E, or —OSi(R 1e ) 3 ,
R 1e is independently lower alkyl optionally substituted by substituent E, carbocyclyl optionally substituted by substituent E, heterocyclyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E,
R 2d is hydrogen, lower alkyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E,
R 4d is lower alkyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E,
R 6d is lower alkyl optionally substituted by substituent E, or lower alkenyl optionally substituted by substituent E,
Substituent E is selected from the group consisting of halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocyclyl optionally substituted by substituent F, heterocyclyl optionally substituted by substituent F, carbocyclyl lower alkyloxy optionally substituted by substituent F, heterocyclyl lower alkyloxy optionally substituted by substituent F, carbocyclyl lower alkylthio optionally substituted by substituent F, heterocyclyl lower alkylthio substituted by substituent F, carbocyclyl lower alkylamino optionally substituted by substituent F, heterocyclyl lower alkylamino optionally substituted by substituent F, carbocyclyloxy optionally substituted by substituent F, heterocyclyloxy optionally substituted by substituent F, carbocyclylcarbonyl optionally substituted by substituent F, heterocyclylcarbonyl optionally substituted by substituent F, carbocyclylaminocarbonyl optionally substituted by substituent F, heterocyclylaminocarbonyl optionally substituted by substituent F, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkyloxy carbonylamino, lower alkylamino, lower alkylcarbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, and lower alkylsulfonylamino; and,
Substituent F is selected from the group consisting of halogeno, hydroxy, carboxy, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, and lower alkyloxy;
with (R)-3-amino-butan-1-ol, to obtain a compound shown by formula (X5):

(Step E)
reacting the compound shown by formula (X5) with a compound shown by formula (V6):

(wherein R x is as defined above)
to obtain a compound shown by formula (X6):

and
(Step F)
reacting the compound shown by formula (X6)
through hydroxy deprotection when R 1d is lower alkyloxy optionally substituted by substituent E, carbocyclyl lower alkyloxy optionally substituted by substituent E, heterocyclyl lower alkyloxy optionally substituted by substituent E, or —Si(R 1e ) 3 ,
with (CH 3 ) 3 —Si—I, BBr 3 , or BF 3 .Et 2 O when R 1d is methyloxy,
with Pd-C/H 2 or Raney-Ni when R 1d is benzyloxy,
with (CH 3 ) 4 N + F − when R 1d is —OSi(CH 3 ) 3 ,
with (CH 3 ) 3 SiO − K + or CH 3 ) 3 SiO − Li + followed by addition of aqueous mineral acid,
when R 1d is halogen, or
with a halogenating agent selected from the group consisting of N-bromosuccinimide, N-chlorosuccinimide and sulfuryl chloride followed by addition of (CH 3 ) 3 SiO − K + or CH 3 ) 3 SiO − Li + and aqueous mineral acid,
when R 1d is hydrogen,
to obtain the compound shown by formula (Y1) or a pharmaceutically acceptable salt thereof.

2. The method according to claim 1 , wherein R x is carbocyclyl lower alkyl optionally substituted by substituent E.

3. The method according to claim 1 , wherein R x is 2,4-difluorobenzyl.

4. A method of producing a compound shown by formula (Y1) or a pharmaceutically acceptable salt thereof:

(wherein R x is carbocyclyl optionally substituted by substituent E, heterocyclyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E)
comprising the following steps:
(Step C′)
reacting the compound shown by formula (X4′):

with a compound shown by formula (V3′):

(wherein L d is selected from halogen, —OSO 2 CH 3 , —OSO 2 CF 3 , —OSO 2 Ph and —OSO 2 PhCH 3 ) to obtain a compound shown by formula (X4),

(Step D)
reacting the compound shown by formula (X4)
wherein
R 1d is hydrogen, halogen, lower alkyloxy optionally substituted by substituent E, carbocyclyl lower alkyloxy optionally substituted by substituent E, heterocyclyl lower alkyloxy optionally substituted by substituent E, or —OSi(R 1e ) 3 ,
R 1e is independently lower alkyl optionally substituted by substituent E, carbocyclyl optionally substituted by substituent E, heterocyclyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E,
R 2d is hydrogen, lower alkyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E,
R 4d is lower alkyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E,
R 6d is lower alkyl optionally substituted by substituent E, or lower alkenyl optionally substituted by substituent E,
Substituent E is selected from the group consisting of halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocyclyl optionally substituted by substituent F, heterocyclyl optionally sub

Assignees

• Shionogi & Co
• Shinogi Co

Inventors

• Sumino Yukihito
• Masui Moriyasu
• Yamada Diasuke
• Ikarashi Fumiya
• Okamoto Kazuya

Classifications

• A61P31/18

  for HIV · CPC title

• C07D213/80

  in position 3 · CPC title

• C07B2200/13

  Crystalline forms, e.g. polymorphs · CPC title

• C07D213/79

  Acids; Esters · CPC title

• C07D211/94

  Oxygen atom, e.g. piperidine N-oxide · CPC title